Diagnosis and treatment of Hemiplegia

Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

hemiplegia AND rehabilitation

Searching the Web

AHA ASA acute ischemic stroke guideline treatment thrombolysis thrombectomy 2026

Quick answer

Hemiplegia means paralysis or severe weakness of one side of the body. It is a neurological sign, not a diagnosis. A sudden new hemiplegia should be treated as a stroke emergency until proven otherwise.

When to seek emergency care

Call emergency services immediately for sudden weakness of the face, arm, or leg on one side, especially with speech difficulty, facial droop, vision loss, severe imbalance, confusion, or sudden severe headache. Note the exact time the person was last known well. Do not give food, drink, or aspirin unless instructed by clinicians, because the cause may be bleeding rather than a clot.

Common causes

  • Stroke: ischemic stroke from an arterial blockage, or hemorrhagic stroke from bleeding. This is the leading acute cause.
  • Brain tumor, abscess, head injury, or subdural hematoma
  • Demyelinating disease, such as multiple sclerosis
  • Brain infection or inflammation
  • Migraine with motor aura, seizures with temporary post-seizure weakness
  • Spinal cord disease, though the pattern often differs
  • Functional neurological disorder, after structural causes have been properly excluded
  • In children, cerebral palsy can cause longstanding spastic hemiplegia.

Diagnosis

1. Clinical assessment

Clinicians establish:
  • Onset and time course: sudden onset favors stroke; gradual progression can suggest tumor or another structural disease.
  • Associated symptoms: aphasia, neglect, visual-field loss, headache, seizure, altered consciousness, sensory loss, swallowing difficulty.
  • Risk factors: hypertension, diabetes, smoking, atrial fibrillation, high cholesterol, anticoagulant use, recent trauma.
Neurological examination assesses muscle power, tone, reflexes, sensation, coordination, cranial nerves, speech, gait, and cortical signs. A lesion above the crossing of motor pathways in the brain generally produces weakness on the opposite side of the body.

2. Emergency tests for suspected acute stroke

  • Immediate non-contrast CT brain to distinguish hemorrhage from ischemia
  • CT angiography or MR angiography to identify large-vessel blockage
  • MRI with diffusion imaging when needed, especially if CT is initially unrevealing
  • Blood glucose, full blood count, electrolytes, kidney function, coagulation tests, ECG, and oxygen assessment
  • Further cause evaluation: carotid imaging, echocardiography, prolonged rhythm monitoring for atrial fibrillation, and vascular-risk assessment.

Treatment

Treatment is directed at the cause and begins with stabilizing airway, breathing, circulation, glucose, temperature, swallowing safety, and prevention of complications.

A. Acute ischemic stroke

If imaging confirms an ischemic stroke and the patient is eligible:
  • Intravenous thrombolysis may be used rapidly in an appropriate time window after onset, following assessment for bleeding risk and contraindications.
  • Mechanical thrombectomy may remove a clot in selected patients with a large-vessel occlusion. It can benefit carefully selected patients even many hours after onset, depending on imaging and clinical criteria.
  • Antiplatelet therapy, commonly aspirin, is started when safe and once hemorrhage has been excluded. The exact timing depends on whether thrombolysis was used.
  • Anticoagulation is used for selected causes such as atrial fibrillation, but usually not immediately in every patient. Timing depends on infarct size and bleeding risk.
  • Control oxygen deficiency, fever, markedly abnormal glucose, dehydration, and blood pressure according to stroke protocols.

B. Hemorrhagic stroke

Management may include:
  • Rapid blood-pressure management
  • Reversal of anticoagulants when applicable
  • Neurosurgical or neurointerventional assessment for evacuation, aneurysm treatment, hydrocephalus, or raised intracranial pressure
  • Intensive monitoring and management of complications.
Steroids do not treat routine ischemic stroke-related brain swelling.

C. Treating the underlying non-stroke cause

  • Tumor or abscess: neurosurgical, oncology, antimicrobial, and sometimes steroid treatment according to cause
  • Seizure-related weakness: manage seizures and confirm that weakness resolves as expected
  • Multiple sclerosis relapse: specialist-directed treatment
  • Functional neurological disorder: clear explanation, neurological and rehabilitation care, and treatment of contributing psychological symptoms where present.

Rehabilitation

Rehabilitation should start early once medically safe and is often the most important determinant of independence.
  • Physiotherapy: strengthening, task-specific practice, balance, walking, transfers, range-of-motion work, and prevention of contractures.
  • Occupational therapy: dressing, bathing, hand function, home adaptations, work and driving assessment.
  • Speech and language therapy: aphasia, communication, cognition, and swallowing assessment.
  • Swallowing management: screen before oral food or fluids; use appropriate diet texture or tube feeding if needed.
  • Spasticity treatment: regular stretching and positioning, splints or orthoses, physiotherapy; oral agents or botulinum toxin injections may be considered for focal problematic spasticity.
  • Mobility aids: ankle-foot orthosis, cane, walker, wheelchair, and fall-prevention strategies as appropriate.
  • Psychological care: screen and treat depression, anxiety, fatigue, sleep issues, and caregiver strain.
Recent systematic reviews on adjunctive acupuncture or robotic rehabilitation exist, but these should not replace standard multidisciplinary rehabilitation. Their benefit and suitability vary, and the core treatment remains intensive, goal-directed rehabilitation.

Preventing complications and recurrence

  • Prevent pressure injuries, shoulder pain/subluxation, falls, aspiration pneumonia, deep-vein thrombosis, urinary issues, and constipation.
  • Manage blood pressure, diabetes, cholesterol, smoking, weight, alcohol intake, sleep apnea, and physical inactivity.
  • For stroke survivors, use cause-specific secondary prevention: antiplatelet or anticoagulant therapy when indicated, statin therapy where appropriate, and carotid intervention in selected people with significant symptomatic carotid stenosis.
Key point: new or worsening hemiplegia is an emergency. Prompt imaging and stroke-team treatment can prevent permanent disability.

Find the latest guidelines for acute stroke treatment

Reading File
Reading File
Searching the Web

2026 Guideline Early Management Patients Acute Ischemic Stroke AHA ASA published

Searching the Web

latest acute intracerebral hemorrhage guideline 2025 2026 AHA ASA ESO

Searching the Web

2025 2026 acute ischemic stroke guidelines tenecteplase thrombectomy recommendations

Searching PubMed

acute ischemic stroke AND guideline

Searching PubMed

intracerebral hemorrhage AND guideline

Finding Sources
Finding Sources
Reading Web Page

https://www.ahajournals.org/guidelines/acute-ischemic-stroke

Reading Article

PMID: 40401775

Searching PubMed

acute ischemic stroke AND thrombectomy

The latest major guideline for acute ischemic stroke is the 2026 AHA/ASA Guideline for the Early Management of Patients With Acute Ischemic Stroke, published January 26, 2026. It replaces the 2018 guideline and 2019 update. Its full citation is Prabhakaran et al., Stroke (2026), DOI: 10.1161/STR.0000000000000513. The AHA guideline announcement confirms the expanded adult recommendations and first detailed pediatric guidance.

Key treatment updates in the 2026 AHA/ASA ischemic-stroke guideline

  • Treat suspected stroke as an emergency: rapid EMS recognition, pre-notification, urgent brain imaging, and coordinated transfer to a stroke-capable or thrombectomy-capable center.
  • IV thrombolysis: for eligible adults within 4.5 hours of last-known-well, either tenecteplase or alteplase is recommended. Tenecteplase has practical advantages because it is given as a single IV bolus.
  • Extended-window thrombolysis: selected patients with unknown-onset stroke or presentation beyond 4.5 hours may be considered for IV thrombolysis when advanced imaging shows salvageable ischemic brain tissue.
  • Mechanical thrombectomy: eligibility is broadened. It remains central for large-vessel occlusion and is recommended in appropriately selected patients up to 24 hours from last-known-well, based on vessel imaging and brain-tissue imaging. The guideline incorporates newer evidence for patients with larger ischemic cores and some posterior-circulation occlusions.
  • Do not delay thrombectomy: if a patient qualifies for both IV thrombolysis and thrombectomy, give IV thrombolysis promptly but do not postpone endovascular treatment.
  • Mild stroke: distinguish disabling from non-disabling deficits. Disabling symptoms may warrant thrombolysis even when the NIHSS score is low; dual antiplatelet therapy is favored rather than thrombolysis for selected non-disabling presentations.
  • Supportive care: avoid hypoxia, treat fever, screen swallowing before oral intake, and avoid overly intensive glucose or blood-pressure reduction without a specific indication.
  • Pediatric stroke: the guideline provides its first dedicated recommendations for children, emphasizing urgent MRI/MRA where feasible and specialist stroke-center involvement.
For spontaneous intracerebral hemorrhage, the newest broad evidence-based source is the 2025 ESO/EANS guideline on stroke due to spontaneous intracerebral hemorrhage, PMID: 40401775. It supports specialist stroke-unit care and secondary-prevention blood-pressure reduction, and addresses acute BP management, anticoagulant reversal, surgical options, VTE prevention, seizures, and prognosis. It advises against routine platelet transfusion and against routine preventive antiseizure treatment in patients without seizures. See the 2025 ESO/EANS ICH guideline abstract.
For hemorrhagic stroke and acute BP targets specifically, the ESO directory lists a 2025 update to the ESO guideline on blood-pressure management in acute ischemic stroke and intracerebral hemorrhage. It also lists a 2026 ESO/EANS/ESMINT guideline for aneurysmal subarachnoid hemorrhage. These are indexed in the ESO guideline directory.
These documents guide clinicians and local stroke protocols. They should not be used for self-triage: new face, arm, or leg weakness, speech disturbance, visual loss, severe imbalance, or sudden severe headache requires emergency services immediately.
This is a shared conversation. Sign in to Orris to start your own chat.